Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control After Pediatric Adenotonsillectomy
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT07870447
- Phase
- PHASE1/PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Adenotonsillectomy
- Postoperative Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Celecoxib — DRUGOral celecoxib 6 mg/kg per dose (max 100 mg), given the evening before surgery and the morning of surgery
- Acetaminophen — DRUGIntra-operative acetaminophen (Tylenol)
- Dexamethasone — DRUGIntra-operative dexamethasone (Decadron)
Study Details
This is an open-label randomized study of approximately 500 pediatric patients (2-18 years of age, weighing more than 10 kg) undergoing adenotonsillectomy. Participants are assigned to a preoperative multimodal analgesic regimen (oral celecoxib the evening before and the morning of surgery, plus intra-operative dexamethasone and acetaminophen) or to standard of care (no pre-operative medication; intra-operative dexamethasone and acetaminophen). The primary aim is to compare postoperative pain control, measured by rescue analgesic consumption, over the first 72 hours after surgery. Secondary aims assess safety (postoperative bleeding and adverse medication events) and feasibility (healthcare utilization and caregiver satisfaction).
Key Dates
- First listed
- Oct 13, 2026
- Start date
- Nov 1, 2026
- Status verified
- Oct 2026
- Primary completion
- Aug 30, 2028
- Completion
- Dec 30, 2029
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Pre-operative CelecoxibPediatric patients (2-18 years, \>10 kg) undergoing adenotonsillectomy who receive oral celecoxib (6 mg/kg, max 100 mg) the evening before surgery and the morning of surgery, plus intra-operative dexamethasone (Decadron) and acetaminophen (Tylenol). Post-operative regimen is the attending's standard of care.
- Active Comparator: No pre-operative medicationPediatric patients (2-18 years, \>10 kg) undergoing adenotonsillectomy who receive no pre-operative medication; intra-operative dexamethasone (Decadron) and acetaminophen (Tylenol) only. Post-operative regimen is the attending's standard of care.
Primary Outcome Measure
Rescue Analgesic Use in PACU [ Time Frame: PACU Stay (PACU arrival to PACU discharge) - Approximately 3 Hours ]
Central Contacts
- Zahrah Taufique, MD646-501-7890
- Jamie Schlacter, MD224-545-9048
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | - |
Find similar trials in New York, NY
Related Studies
- Rectus Sheath Block in Cardiac SurgeryRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated CoagulationPHASE4 · Not Yet Recruiting · NYU Langone Health · New York, New York
- Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic SurgeryRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Use of a Vibration Tool for Postoperative Pain Control in Distal Radius FracturesNot Yet Recruiting · Northwestern University · Chicago, Illinois